KCNH2 and cardiac arrhythmia: It is premature to ascribe risk of cardiac arrhythmias or other adverse effects to celecoxib, but with more than one million prescriptions of Celebrex every month, the data make a case for exploring the implications of its inhibition of hERG and other human channels critical to cardiac rhythm and other physiological functions.